echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Zhejiang reference preparation (original research drug) hanging network procurement information combing results are announced

    Zhejiang reference preparation (original research drug) hanging network procurement information combing results are announced

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On August 19, the Zhejiang Pharmaceutical equipment Procurement Center released the "Zhejiang Reference Preparation (Original Research Drug) Hanging Network Procurement Information Combing Results (21)", which said that in accordance with the spirit of the "Zhejiang Province To Enhance the Function of the Centralized Drug Procurement Platform to Promote the Full Coverage of Medical Insurance Drug Payment Standards" (Zhejiang Medical Insurance Fa [2020] No.
    14), through the enterprise declaration, carding and other procedures, the industry applied for the online procurement of the reference preparation (original research drug) product information is publicized
    .
    Announcement period: From August 19 to August 25, 2022
    .
     

    According to the preliminary combing result table of the application for the hanging net of the reference preparation (original research drug) product released, there are 10 provinces of Agathatraban Injection (2ml: 10mg) that Tianjin Tianbian Pharmaceutical Co.
    , Ltd.
    bid for, namely Beijing, Hebei, Henan, Hubei, Hunan, Jiangsu, Shandong, Sichuan, Tianjin and Yunnan, with a minimum difference ratio unit price of 260 yuan
    .
     

    Bozhou Jiuzhoutong Pharmaceutical Co.
    , Ltd.
    bid for Tirofiban hydrochloride injection (50ml: 12.
    5mg) hanging net (winning bid) in 20 provinces, namely Beijing, Chongqing, Fujian, Guangxi, Guizhou, Hainan, Hebei, Heilongjiang, Hubei, Hunan, Jilin, Jiangxi, Liaoning, Inner Mongolia, Ningxia, Shandong, Shanxi, Sichuan, Xinjiang, Yunnan
    .
    Among them, the minimum difference ratio unit price in Ningxia is 1480.
    32 yuan, Yunnan is 1495.
    27 yuan, and other provinces are 1375.
    65 yuan
    .

     

    Sinopharm Holdings Distribution Center Co.
    , Ltd.
    bid for 11 provinces with Sinarcacel hydrochloride tablets (25mg) hanging net (winning bid), namely Chongqing, Gansu, Guangxi, Guizhou, Hubei, Hunan, Shandong, Sichuan, Tianjin, Xinjiang and Yunnan
    .
    The minimum difference ratio unit price is 18.
    4124 yuan
    .

     

    Fresenius Kabi Huarui Pharmaceutical Co.
    , Ltd.
    bid for fat milk amino acids (17) glucose (19%) injection [(1026ml (fat emulsion injection (20%) 200ml, compound amino acid (17AA) injection 300ml, glucose injection (19%) 526ml)] there are 22 provinces with hanging net (winning bid), Beijing, Gansu, Guangxi, Guizhou, Hainan, Henan, Heilongjiang, Hubei, Hunan, Jilin, Jiangsu, Jiangxi, Liaoning, Inner Mongolia, Ningxia, Qinghai, Shandong, Sichuan, Tianjin, Tibet, Xinjiang, Yunnan
    .
    Among them, the minimum difference ratio unit price in Gansu is 202.
    44 yuan, Hainan is 253.
    16 yuan, Henan, Hubei, Jilin, Jiangsu and Ningxia are 202.
    5 yuan, Jiangxi is 267.
    83 yuan, and other provinces are 202 yuan
    .

     

    Sumitomo Pharmaceutical (Suzhou) Co.
    , Ltd.
    bid for 10 provinces with Meropenem (0.
    5g) for injection (winning the bid), namely Background, Gansu, Henan, Hunan, Jilin, Jiangsu, Qinghai, Shandong, Tianjin and Yunnan
    .
    The minimum difference ratio unit price is 155.
    9 yuan
    .

     

    According to the publicity, the way to reflect the problem: During the publicity period, units and individuals can reflect the problem
    to our center in writing.
    Where the problem is reflected in the name of the unit, the official seal of the unit shall be affixed; If the problem is reflected in the name of the individual, it is recommended to sign the real name of the person and indicate the contact information
    .
    He also demanded that the principle of seeking truth from facts should be adhered to in reflecting problems, and false accusations should be opposed
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.